LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset - HMS LINCS Database

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)

Download: Excel (XLSX), Comma-separated (CSV)

Filter results: >>>>

<
<<
Previous
Page 1 of 67
Next
>>
>
1 to 25 of 1656 records
per page:

Small Molecule	barcode	cell_count	frac_dead	corpse_count	cell_count_dead	row	column	agent	concentration	role	timepoint	replicate	cell_line	dead_count	fraction_dead	cell_count__time0	dead_count__time0	cell_count__ctrl	dead_count__ctrl	fraction_dead__ctrl	increase_fraction_dead	GRvalue
Alpelisib	180622_BG_7	20159	0.0197	38	359	12	5	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_6	397	0.0193	832.0	168.3	20016	537.9	0.0261	-0.00681	1.0031
Alpelisib	180622_BG_7	19340	0.0239	53	410	6	7	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_5	463	0.0234	832.0	168.3	20016	537.9	0.0261	-0.00274	0.9851
Alpelisib	180622_BG_8	21026	0.0292	65	551	9	21	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_7	616	0.0285	832.0	168.3	20016	537.9	0.0261	0.00234	1.0216
Alpelisib	180622_BG_7	19392	0.0205	36	363	10	21	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_5	399	0.0202	832.0	168.3	20016	537.9	0.0261	-0.00596	0.9862
Alpelisib	180622_BG_6	19478	0.0250	114	375	13	4	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_1	489	0.0245	832.0	168.3	20016	537.9	0.0261	-0.00163	0.9882
Alpelisib	180622_BG_7	18491	0.0259	60	420	3	18	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_4	480	0.0253	832.0	168.3	20016	537.9	0.0261	-0.00082	0.9657
Alpelisib	180622_BG_6	20368	0.0292	92	505	12	14	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_3	597	0.0285	832.0	168.3	20016	537.9	0.0261	0.00235	1.0076
Alpelisib	180622_BG_7	19415	0.0171	43	289	13	15	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_6	332	0.0168	832.0	168.3	20016	537.9	0.0261	-0.00931	0.9867
Alpelisib	180622_BG_6	19859	0.0234	117	351	3	12	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_1	468	0.0230	832.0	168.3	20016	537.9	0.0261	-0.00310	0.9966
Alpelisib	180622_BG_7	18889	0.0280	63	468	5	4	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_4	531	0.0273	832.0	168.3	20016	537.9	0.0261	0.00122	0.9749
Alpelisib	180622_BG_8	20045	0.0266	43	491	14	4	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_8	534	0.0259	832.0	168.3	20016	537.9	0.0261	-0.00018	1.0006
Alpelisib	180622_BG_8	20885	0.0230	44	437	14	10	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_9	481	0.0225	832.0	168.3	20016	537.9	0.0261	-0.00361	1.0186
Alpelisib	180622_BG_6	19006	0.0237	107	346	13	13	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_2	453	0.0233	832.0	168.3	20016	537.9	0.0261	-0.00285	0.9776
Alpelisib	180622_BG_6	19252	0.0264	95	416	14	3	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_3	511	0.0259	832.0	168.3	20016	537.9	0.0261	-0.00027	0.9831
Alpelisib	180622_BG_6	19175	0.0244	113	357	7	14	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_1	470	0.0239	832.0	168.3	20016	537.9	0.0261	-0.00220	0.9814
Alpelisib	180622_BG_6	20639	0.0282	113	473	8	11	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_2	586	0.0276	832.0	168.3	20016	537.9	0.0261	0.00148	1.0134
Alpelisib	180622_BG_7	18739	0.0227	59	368	3	13	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_4	427	0.0223	832.0	168.3	20016	537.9	0.0261	-0.00385	0.9715
Alpelisib	180622_BG_7	20195	0.0272	59	492	8	17	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_5	551	0.0266	832.0	168.3	20016	537.9	0.0261	0.00043	1.0039
Alpelisib	180622_BG_8	20606	0.0246	42	465	11	6	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_8	507	0.0240	832.0	168.3	20016	537.9	0.0261	-0.00211	1.0127
Alpelisib	180622_BG_8	19276	0.0242	37	431	13	22	Alpelisib	0.003326667	treatment	72	2	MCF10A-GM_9	468	0.0237	832.0	168.3	20016	537.9	0.0261	-0.00242	0.9836
Alpelisib	180622_BG_6	19494	0.0254	49	448	13	15	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_2	497	0.0249	832.0	168.3	20016	537.9	0.0261	-0.00126	0.9885
Alpelisib	180622_BG_6	19108	0.0293	76	486	13	21	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_3	562	0.0286	832.0	168.3	20016	537.9	0.0261	0.00245	0.9799
Alpelisib	180622_BG_8	20727	0.0319	68	595	13	21	Alpelisib	0.00998	treatment	72	2	MCF10A-GM_7	663	0.0310	832.0	168.3	20016	537.9	0.0261	0.00487	1.0153
Alpelisib	180622_BG_8	19995	0.0267	39	496	5	18	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_7	535	0.0261	832.0	168.3	20016	537.9	0.0261	-0.00007	0.9995
Alpelisib	180622_BG_7	18809	0.0250	50	421	14	3	Alpelisib	0.033266667	treatment	72	2	MCF10A-GM_6	471	0.0244	832.0	168.3	20016	537.9	0.0261	-0.00170	0.9731

<
<<
Previous
Page 1 of 67
Next
>>
>
1 to 25 of 1656 records
per page:

HMS LINCS Project

LINCS MCF 10A Common Project: Fixed-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Repeat performed by Scientist B in 2019 to assess reproducibility. Dataset 1 of 2: Normalized growth rate inhibition values. - Dataset (ID:20359)